Status:
COMPLETED
Safety of Direct Oral Anticoagulant During Pregnancy
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Thromboembolic Disease
Eligibility:
FEMALE
10-60 years
Brief Summary
Pregnancy is a major risk factor of thromboembolic disease (2 to 10 increased risk of thromboembolic event for pregnant women). This risk is related to the physiological changes inducing venous stasis...
Eligibility Criteria
Inclusion
- pregnant women exposed to an anticoagulant
Exclusion
- women not covered by national health insurrance
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
1755558 Patients enrolled
Trial Details
Trial ID
NCT06179823
Start Date
January 1 2019
End Date
December 31 2020
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nancy teaching hospital
Nancy, France, 5400